Purchases and Sales Made in Q2 2025 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q2 2025. The information is specifically focused on institutions that hold shares of ROCKET PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Aug 13, 2025
Q2 2025
|
Myda Advisors LLC
Inwood, NY |
SELL
|
- |
-360K- 78.28% |
$840K - $2.89M
|
100K
$291K
|
|
Aug 11, 2025
Q2 2025
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-495K- 7.48% |
$1.15M - $3.97M
|
6.12M
$17.8M
|
|
Aug 14, 2025
Q2 2025
|
Baker Bros. Advisors LP
New York, NY |
SELL
|
- |
-545K- 49.68% |
$1.27M - $4.37M
|
552K
$1.61M
|
|
Aug 13, 2025
Q2 2025
|
Comerica Bank
|
SELL
|
- |
-816K- 99.96% |
$1.9M - $6.53M
|
288
$838
|
|
Aug 14, 2025
Q2 2025
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-1.35M- 89.66% |
$3.15M - $10.8M
|
156K
$454K
|
|
Aug 14, 2025
Q2 2025
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.76M- 47.55% |
$4.1M - $14.1M
|
1.94M
$5.66M
|
|
Aug 14, 2025
Q2 2025
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-1.94M- 63.87% |
$4.53M - $15.6M
|
1.1M
$3.2M
|
|
Aug 14, 2025
Q2 2025
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-3.26M- 98.93% |
$7.59M - $26.1M
|
35.3K
$103K
|